会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 환삼덩굴 추출물을 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 조성물
    • 用于预防或治疗包含HUMULUS JAPONICUS提取物作为活性成分的神经变性疾病的组合物
    • KR1020160008042A
    • 2016-01-21
    • KR1020140087601
    • 2014-07-11
    • 한국생명공학연구원서울대학교산학협력단
    • 이철호김경심오원근김용훈황정환김진웅김대덕강영박태신박혜연유영경이인복최동희
    • A61K36/185A23L1/30
    • A61K36/185A23L33/105A23V2200/322A61K2236/33A61K2236/333
    • 본발명은환삼덩굴() 추출물또는그의분획물을유효성분으로포함하는퇴행성뇌질환의예방또는치료용약학적조성물에관한것으로서, 보다상세하게는도파민성신경세포사의억제효과및 산화스트레스에대한신경세포의보호효과와, 인지능력및 기억력개선효과를갖는환삼덩굴추출물또는그의분획물을유효성분으로포함하는퇴행성뇌질환의예방또는치료용약학적조성물및 예방또는개선용건강기능식품에관한것이다. 본발명의환삼덩굴() 추출물또는그의분획물을유효성분으로함유하는조성물은도파민성신경세포사를억제하고, 산화스트레스에대한신경세포의보호효과를지닐뿐만아니라, 파킨슨병및 알츠하이머병과같은퇴행성뇌질환을지닌동물모델에서인지능력및 기억력개선효과를나타내므로, 알츠하이머, 파킨슨병, 루게릭병, 경도인지장애, 뇌졸중, 및헌팅턴병 등을포함하는퇴행성뇌질환의예방이나치료를위한식품또는의약품으로유용하게사용될수 있다.
    • 本发明涉及用于预防或治疗退行性脑病的药物组合物,其含有葎草提取物或其一部分,更具体地,涉及用于预防或治疗退行性脑病的药物组合物或用于预防或减轻的健康功能性食品 退化性脑疾病,含有葎草提取物或其部分,其有效抑制多巴胺能神经元细胞死亡,保护神经元免受氧化应激,并提高认知能力和记忆力。 包含葎草提取物或其部分的组合物抑制多巴胺能神经元细胞死亡,保护神经元免受氧化应激,并改善具有退行性脑疾病如帕金森病,阿尔茨海默氏病等的动物模型的认知能力和记忆能力, 因此能够有效地用作食品或药物,用于预防或治疗退行性脑疾病,包括阿尔茨海默病,帕金森病,Lou Gehrig病,轻度认知障碍,中风,亨廷顿病 疾病等
    • 6. 发明公开
    • 팥꽃나무 추출물로부터 분리된 화합물을 포함하는 신경퇴행성 질환 예방 또는 치료용 약학적 조성물
    • 用于预防或治疗包含从DAPHNE GENKWA提取物分离的化合物的神经损伤性疾病的药物组合物
    • KR1020130057878A
    • 2013-06-03
    • KR1020110123848
    • 2011-11-24
    • 한국생명공학연구원
    • 김원곤한백수김경심김광수강영미김유진김천형손미진정회윤
    • A61K31/357A61K36/83A23L1/30
    • A61K31/357A23L33/105A23V2200/322A61K36/83A61K2236/30
    • PURPOSE: A pharmaceutical composition containing genkwanine N or yuanhuacine which is isolated from a Daphne genkwa extract, or a pharmaceutically acceptable salt thereof for preventing or treating neurodegenerative diseases is provided to recover suppression of Nurr1 protein activation due to nerve damage without side effects. CONSTITUTION: A pharmaceutical composition for preventing or treating neurodegenerative diseases contains a terpenoid compound selected from a group consisting of genkwanine N and yuanhuacine, or a pharmaceutically acceptable salt thereof as an active ingredient. The neurodegenerative diseases are selected from a group consisting of Parkinson's disease(PD), Alzheimer's disease(AD), amyotrophic lateral sclerosis(ALS), Huntington's disease(HD), frontotemporal dementia, cortico basal degeneration, and progressive supranuclear palsy(PSP). Genkwanine N and yuanhuacine are derived from a Daphne genkwa extract. A pharmaceutical composition for preventing or treating diseases caused by Nurr1 functional disorder contains a terpenoid compound selected from a group consisting of genkwanine N and yuanhuacine, or a pharmaceutically acceptable salt thereof as an active ingredient.
    • 目的:提供一种从达芙妮genkwa提取物或其药学上可接受的盐分离出来的用于预防或治疗神经退行性疾病的genkwanine N或元华辛的药物组合物,用于恢复由于神经损伤引起的Nurr1蛋白激活的抑制而没有副作用。 构成:用于预防或治疗神经变性疾病的药物组合物含有选自由发明人N和元华辛组成的组的萜类化合物或其药学上可接受的盐作为活性成分。 神经变性疾病选自帕金森病(PD),阿尔茨海默氏病(AD),肌萎缩性侧索硬化(ALS),亨廷顿病(HD),额颞叶痴呆,皮层基底变性和进行性核上性麻痹(PSP)组。 Genkwanine N和元华辛衍生自达芙妮genkwa提取物。 用于预防或治疗由Nurr1功能障碍引起的疾病的药物组合物含有选自由发明人N和元华辛组成的组的萜类化合物或其药学上可接受的盐作为活性成分。
    • 10. 发明公开
    • 팥꽃나무 추출물을 포함하는 조성물
    • 包含作为活性成分的DAPHNE GENKWA的提取物的组合物
    • KR1020120113924A
    • 2012-10-16
    • KR1020110031614
    • 2011-04-06
    • 한국생명공학연구원
    • 김원곤한백수김경심김광수김천형정회윤강영미손미진
    • A61K36/83A61P25/16A61P25/24A61P25/00
    • PURPOSE: A pharmaceutical composition containing Daphne genkwa extract is provided to activate Nurr1 and to prevent or treat diseases caused by Nurr1 functional disorder. CONSTITUTION: A pharmaceutical composition for preventing or treating diseases caused by Nurr1 functional disorder contains Daphne genkwa extract as an active ingredient. The extract is prepared from stems and roots of Daphne genkwa using organic solvent. A functional food additive with an effect of preventing or treating diseases caused by Nurr1 functional disorder contains the extract as an active ingredient. The composition is administered in the form of liquid, powder, aerosol, capsule, enteric tablet, capsule, or suppository. [Reference numerals] (AA) FOLD VS DMSO; (BB) Daphne genkwa
    • 目的:提供含有Daphne genkwa提取物的药物组合物,以激活Nurr1并预防或治疗由Nurr1功能障碍引起的疾病。 构成:用于预防或治疗由Nurr1功能紊乱引起的疾病的药物组合物含有达芙妮genkwa提取物作为活性成分。 使用有机溶剂从Daphne genkwa的茎和根制备提取物。 具有预防或治疗由Nurr1功能障碍引起的疾病作用的功能性食品添加剂含有提取物作为活性成分。 组合物以液体,粉末,气溶胶,胶囊,肠溶片,胶囊或栓剂的形式施用。 (AA)FOLD VS DMSO; (BB)达芙妮genkwa